HK1054688A1 - Compositions comprising modafinil compounds - Google Patents
Compositions comprising modafinil compoundsInfo
- Publication number
- HK1054688A1 HK1054688A1 HK03106970.8A HK03106970A HK1054688A1 HK 1054688 A1 HK1054688 A1 HK 1054688A1 HK 03106970 A HK03106970 A HK 03106970A HK 1054688 A1 HK1054688 A1 HK 1054688A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- modafinil compounds
- modafinil
- compounds
- particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23949000P | 2000-10-11 | 2000-10-11 | |
US64082401A | 2001-10-10 | 2001-10-10 | |
PCT/US2001/031904 WO2002030414A1 (en) | 2000-10-11 | 2001-10-11 | Compositions comprising modafinil compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1054688A1 true HK1054688A1 (en) | 2003-12-12 |
Family
ID=26932616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03106970.8A HK1054688A1 (en) | 2000-10-11 | 2003-09-26 | Compositions comprising modafinil compounds |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1330244B1 (da) |
JP (1) | JP4593074B2 (da) |
AT (1) | ATE417608T1 (da) |
AU (1) | AU1167702A (da) |
BR (1) | BR0114814A (da) |
CY (1) | CY1110061T1 (da) |
CZ (1) | CZ306618B6 (da) |
DE (1) | DE60137069D1 (da) |
DK (1) | DK1330244T3 (da) |
ES (1) | ES2317943T3 (da) |
HK (1) | HK1054688A1 (da) |
NZ (1) | NZ525236A (da) |
PT (1) | PT1330244E (da) |
WO (1) | WO2002030414A1 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US6919378B2 (en) * | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
AU2003247001A1 (en) * | 2002-07-25 | 2004-02-16 | Ranbaxy Laboratories Limited | Processes for the preparation of oral dosage formulations of modafinil |
US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
CA2511992A1 (en) | 2003-02-24 | 2004-09-10 | Mallinckrodt Inc. | Process for preparing benzhydrylthioacetamide |
CN101031290B (zh) * | 2003-09-18 | 2011-09-21 | 赛福伦公司 | 改良释放的莫达非尼药物组合物 |
EP2292213A1 (en) * | 2004-02-06 | 2011-03-09 | Cephalon, Inc. | Compositions comprising a polymorphic form of armodafinil |
AU2007272501A1 (en) * | 2006-07-12 | 2008-01-17 | Elan Pharma International Limited | Nanoparticulate formulations of modafinil |
WO2012006081A1 (en) | 2010-06-29 | 2012-01-12 | Poniard Pharmaceuticals, Inc. | Oral formulation of kinase inhibitors |
WO2012012139A1 (en) | 2010-06-30 | 2012-01-26 | Poniard Pharmaceuticals, Inc. | Synthesis and use of kinase inhibitors |
FR2987267B1 (fr) * | 2012-02-28 | 2015-01-16 | Debregeas Et Associes Pharma | Application du modafinil dans le traitement de substitution des cacainomanes |
CN109715616A (zh) * | 2016-09-27 | 2019-05-03 | 诺华股份有限公司 | 用于结晶有机化合物的表面活性剂体系 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04164024A (ja) * | 1990-10-29 | 1992-06-09 | Sankyo Co Ltd | 医薬物質含有自己乳化型脂肪乳剤組成物の製造方法 |
FR2702968B1 (fr) * | 1993-03-23 | 1995-06-23 | Lafon Labor | Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation . |
FR2706767B1 (da) * | 1993-06-22 | 1995-09-08 | Lafon Labor | |
US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
FR2771004B1 (fr) * | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
AU3843999A (en) * | 1998-05-07 | 1999-11-23 | Elan Corporation, Plc | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
ATE243996T1 (de) * | 1999-01-12 | 2003-07-15 | Merck Sharp & Dohme | Sphäronisiertes selbstemulgierendes system für hydrophobe und wasserempfindliche wirkstoffe |
SK2242003A3 (en) * | 2000-07-27 | 2003-10-07 | Teva Pharma | Crystalline and pure modafinil, and process of preparing the same |
-
2001
- 2001-10-11 DE DE60137069T patent/DE60137069D1/de not_active Expired - Lifetime
- 2001-10-11 NZ NZ525236A patent/NZ525236A/xx not_active IP Right Cessation
- 2001-10-11 AT AT01979747T patent/ATE417608T1/de active
- 2001-10-11 CZ CZ2003-1020A patent/CZ306618B6/cs not_active IP Right Cessation
- 2001-10-11 PT PT01979747T patent/PT1330244E/pt unknown
- 2001-10-11 JP JP2002533857A patent/JP4593074B2/ja not_active Expired - Lifetime
- 2001-10-11 EP EP01979747A patent/EP1330244B1/en not_active Expired - Lifetime
- 2001-10-11 BR BR0114814-1A patent/BR0114814A/pt active Search and Examination
- 2001-10-11 DK DK01979747T patent/DK1330244T3/da active
- 2001-10-11 ES ES01979747T patent/ES2317943T3/es not_active Expired - Lifetime
- 2001-10-11 AU AU1167702A patent/AU1167702A/xx active Pending
- 2001-10-11 WO PCT/US2001/031904 patent/WO2002030414A1/en active Search and Examination
-
2003
- 2003-09-26 HK HK03106970.8A patent/HK1054688A1/xx not_active IP Right Cessation
-
2009
- 2009-03-16 CY CY20091100287T patent/CY1110061T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1330244B1 (en) | 2008-12-17 |
DE60137069D1 (de) | 2009-01-29 |
BR0114814A (pt) | 2005-01-25 |
ATE417608T1 (de) | 2009-01-15 |
ES2317943T3 (es) | 2009-05-01 |
EP1330244A1 (en) | 2003-07-30 |
CZ20031020A3 (en) | 2004-03-17 |
DK1330244T3 (da) | 2009-02-16 |
AU1167702A (en) | 2002-04-22 |
NZ525236A (en) | 2004-12-24 |
CY1110061T1 (el) | 2015-01-14 |
JP2004517052A (ja) | 2004-06-10 |
PT1330244E (pt) | 2009-01-27 |
CZ306618B6 (cs) | 2017-04-05 |
JP4593074B2 (ja) | 2010-12-08 |
WO2002030414A1 (en) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110061T1 (el) | Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
DE60134274D1 (en) | Complex enthaltend modafinil und cyclodextrin | |
SG146442A1 (en) | Sulphonamide derivatives, their preparation and use as medicaments | |
IL167187A (en) | Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament | |
AU2001283285A1 (en) | Antimicrobial composition and methods of use in the treatment of disease | |
ZA200301204B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
IL175303A0 (en) | Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same | |
HK1057336A1 (en) | Pharmaceutical solutions of modafinil compounds | |
MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
BG66081B1 (bg) | Състави, съдържащи модафинилни съединения | |
AU2003260241A1 (en) | Buguzhi agent and composition and methods of preparing and administering the same | |
EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
GR1003490B (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης | |
IL160722A0 (en) | Aryloxypropylamines as chemosensitizing agents in the treatment of cancer | |
IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
MXPA03007634A (es) | Derivados de imidazolidina, su preparacion, su uso y preparaciones farmaceuticas que los contienen. | |
AU2002347372A1 (en) | Skin lightening agents, noel compounds, compositions and use | |
AU2001255168A1 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2001247214A1 (en) | Hair treatment compositions and their use | |
AU2003285125A8 (en) | Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor | |
AU2002232433A1 (en) | Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 | |
AU2002217110A1 (en) | Fractions of snake blood, their preparation and use as therapeutic agents | |
AU2003249364A8 (en) | Algal gdp-mannose-3',5'-epimerases and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171011 |